1. You Are At:
  2. English News
  3. India
  4. We have to be more careful about COVID-19 during winter, informs NITI Aayog

We have to be more careful about COVID-19 during winter, informs NITI Aayog

There is a stabilization in the impact of COVID-19 in the country, but we have to be more careful in our hygiene practices as it is a respiratory virus and most respiratory viruses escalate during winter, said Dr VK Paul, Member (Health), NITI Aayog on Tuesday. COVID prevention NITI aayog says people have to be more careful during winters,  VK Paul, COVID-19 during winter

India TV News Desk India TV News Desk
New Delhi Published on: October 13, 2020 21:41 IST
We have to be more careful about COVID-19 during winter, informs NITI Aayog
Image Source : PTI

We have to be more careful about COVID-19 during winter, informs NITI Aayog

There is a stabilization in the impact of COVID-19 in the country, but we have to be more careful in our hygiene practices as it is a respiratory virus and most respiratory viruses escalate during winter, said Dr VK Paul, Member (Health), NITI Aayog on Tuesday.

Speaking at the Health Ministry press briefing, Dr Paul said the people in the country don't have to create such a situation which will be counterproductive. "But we have to be prepared and strictly follow Covid preventive measures. In European countries, the second peak is seen, so we have to be extra cautious. This is also a festive season. There are gatherings. And it is a favourable condition for the virus to create super spreader events."

On the issue of preventing the virus, Dr Paul reiterated the need to wear masks to prevent transmission of the infection.

"The three-ply masks and homemade masks are beneficial for preventing the transmission of COVID-19. N95 masks are beneficial for health workers working in hospitals while surgical masks are effective in general practice use," he said.

Speaking on India's vaccine trial, he said, "Phase two of two Indian indigenous vaccines is nearly completed. In early November we can have the results. The other vaccine is Serum Oxford vaccine-- undergoing phase three trial. Progress is good and by November end we may have results."

Meanwhile, Director General of ICMR, Dr Balram Bhargava, who was also present at the press briefing, answered questions about the reinfection study done by the institute.

"We are taking the cut off of about 100 days if reinfection occurs because we have assumed the life of antibiodies persists for 4 months, by some studies. It is still in progress and we will share the re-infection data soon," said Dr Bhargava.

"A few reinfection cases have been identified in India. There are two in Mumbai, and one in Ahmedabad, so far. As per the World Health Organisation, there are about 24 reinfection cases in the world," he added.

(With ANI inputs)

 

Latest India News

Write a comment